In its revised guidelines, the government said there was no evidence that not requiring supplemental oxygen or continued use of injectable steroids after hospital discharge would benefit Covid-19 patients. Clinical guidelines issued jointly by AIIMS, Indian Council of Medical Research (ICMR) and Covid-19 National Task Force and Joint Monitoring Group warn that anti-inflammatory treatments may lead to the risk of secondary infections such as invasive mucormycosis or ‘black fungus’ ‘.
Under anti-inflammatory or immunomodulatory therapy, the guidelines say, “in Covid-19 patients,” injection of methylprednisolone 0.5 to 1 mg/kg in two divided doses or an equivalent dose of dexamethasone, usually administered 5 to 10 days”. If the patient’s condition stabilizes and/or improves, it can be administered orally.
Adult Covid-19 patients were classified into mild, moderate and severe disease based on upper respiratory symptoms and dyspnea. The government-recommended treatment does not include drugs such as ivermectin, favipiravir and doxycycline. Antiviral drugs such as molnupiravir and monoclonal antibodies are also not included in the guidelines.
Complete News Source : Hindustan Times
